We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Human-Centered AI Tool Predicts Patient’s Sepsis Risk Within Four Hours

By HospiMedica International staff writers
Posted on 28 Aug 2024

Sepsis, a critical and life-threatening response to infection, can quickly lead to organ failure and is highly difficult to diagnose due to its common symptoms such as fever, low blood pressure, and increased heart rate, which mimic many other conditions. More...

Now, an innovative artificial intelligence (AI) tool designed to assist clinicians in making decisions about patients at risk of sepsis introduces a novel feature: it accounts for uncertainties in its predictions and suggests additional information, such as demographic data, vital signs, and lab test results, needed to enhance its accuracy.

The system, called SepsisLab, was developed by scientists at The Ohio State University (Columbus, OH, USA) based on feedback from doctors and nurses in emergency and intensive care settings, where sepsis frequently occurs. These healthcare professionals expressed concerns over existing AI tools that rely solely on electronic health records without incorporating clinical inputs. SepsisLab improves upon this by predicting sepsis risk within a four-hour window while actively identifying and quantifying the importance of missing patient data, visually informing clinicians how certain pieces of information can influence the risk assessment.

This AI system updates its predictions hourly as new patient data is incorporated, continuously refining its accuracy. It also provides clinicians with actionable insights, suggesting which laboratory tests might be most informative and estimating how different clinical interventions could alter the patient's risk of developing sepsis According to the research published Aug. 24 in KDD ’24: Proceedings of the 30th ACM SIGKDD Conference on Knowledge Discovery and Data Mining, incorporating just 8% additional data from lab results and other key variables can decrease uncertainty in the predictions by 70%, enhancing the tool’s accuracy in assessing sepsis risk by 11%.

“The existing model represents a more a traditional human-AI competition paradigm, generating numerous annoying false alarms in ICUs and emergency rooms without listening to clinicians,” said senior study author Ping Zhang, associate professor of computer science and engineering and biomedical informatics at Ohio State. “The idea is we need to involve AI in every intermediate step of decision-making by adopting the ‘AI-in-the-human-loop’ concept. We’re not just developing a tool – we also recruited physicians into the project. This is a real collaboration between computer scientists and clinicians to develop a human-centered system that puts the physician in the driver’s seat.”

Related Links:
The Ohio State University


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.